InsidersTradesSigma
南微医学 Stock: price and directors' dealings · China · SSE / SZSE (CSRC)
Track the 南微医学 share price and the full insider trade history of the company, a publicly traded company based in China. Shares trade on CN CN, under the supervision of SSE / SZSE (CSRC). Operating in the Health Care sector, 南微医学 has logged 16 insider filings. Market capitalisation: €15.3bn. The latest transaction was disclosed on 1 December 2023 (Sale). Among the most active insiders: 芮晨为. Every trade is openly available.
16
Insider Decl.
0
Thresholds
·
10 ops.
Buy Volume
·
6 ops.
Sell Volume
11Σ signal
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Fundamental score
Ranked 6,325 of 25,571 companies
64.4
score / 100
Value48
Quality81
FCF yld3.1%
Earn yld4.0%
EV/EBITDA17.5x
ROE13%
Gross mgn64%
Net mgn18%
Debt/EBITDA0.3x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
Last declaration on 1 December 2023
Declarations16 total
16 of 16 declarations